← Back to Search

Local Anesthetic

Exparel for Cardiothoracic Surgery (EXPAREL Trial)

Phase 4
Waitlist Available
Led By Charles T Klodell, MD
Research Sponsored by Florida Heart and Lung Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from post operative day of cardiac surgery through length of hospital admission and through study completion, an average of one year.
Awards & highlights

EXPAREL Trial Summary

Evaluation of Liposomal Bupivacaine Compared to Usual Care and its Effect on Pain for Cardiac Surgery

EXPAREL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~count the number of days from admission for cardiac surgery to day of hospital discharge through study completion , an average of one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and count the number of days from admission for cardiac surgery to day of hospital discharge through study completion , an average of one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
20% change in opioids use
Secondary outcome measures
Major Adverse Cardiac Effects of Liposomal Bupivacaine
Pain Scores on Post op day 2,3 and 4
Time to Hospital Discharge
+3 more

EXPAREL Trial Design

2Treatment groups
Active Control
Group I: ExparelActive Control2 Interventions
administration of liposomal bupivacaine 266mg/20mL+ 40 mL bupivacaine 0.25% bupivacaine .
Group II: Standard of TherapyActive Control1 Intervention
administration of 0.25% bupivacaine with epinephrine at 1cc/kg total dose

Find a Location

Who is running the clinical trial?

Florida Heart and Lung InstituteLead Sponsor
Charles T Klodell, MDPrincipal InvestigatorFlorida Heart and Lung Institute, HCA Physician Services

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~55 spots leftby Apr 2025